|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 85, 133-135, Copyright © 1984 by American College of Chest Physicians
ARTICLES |
GM Akoun, S Gauthier-Rahman, BJ Milleron, JY Perrot and CM Mayaud
Interstitial pneumonitis developed in a patient who had received a cumulative dose of 985 g of amiodarone in nine years. No other cause for pneumonitis was found. The following findings favor an immunologic mechanism of hypersensitivity due to amiodarone: positive skin and basophil degranulation tests with amiodarone; lymphocytosis and inverted ratio of helper/suppressor T lymphocytes in bronchoalveolar lavage fluid; secretion of leukocyte inhibitory factor, as shown by the inhibition of migration of peripheral blood leukocytes; and positive lymphoblastic transformation in the presence of amiodarone.
This article has been cited by other articles:
![]() |
L. W. Poll, P. May, J.-A. Koch, G. Hetzel, P. Heering, and U. Modder HRCT Findings of Amiodarone Pulmonary Toxicity: Clinical and Radiologic Regression Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 307 - 311. [Abstract] [PDF] |
||||
![]() |
R. Bargout, A. Jankov, E. Dincer, R. Wang, T. Komodromos, O. Ibarra-Sunga, G. Filippatos, and B. D. Uhal Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro Am J Physiol Lung Cell Mol Physiol, May 1, 2000; 278(5): L1039 - L1044. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |